Arkema Balanced Scorecard

Arkema Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

Arkema Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Unlock the Full Balanced Scorecard for Deeper Strategic Insight

This Arkema Balanced Scorecard Analysis gives you a structured view of the company's financial, customer, internal process, and learning and growth priorities. This page already includes a real preview of the actual analysis, so you can review the content and format before buying. Purchase the full version to get the complete ready-to-use report.

Benefits

Icon

Segment Clarity

Segment clarity helps Arkema isolate results across Adhesive Solutions, Advanced Materials, and Coating Solutions, so management can see which unit is lifting margin, cash flow, or pricing power. Arkema reported net sales of €9.5 billion in 2024, making that split useful for tracking where value is created and where action is needed. It also makes corrective moves faster when one segment lags while another stays resilient.

Icon

Market Alignment

A balanced scorecard helps Arkema link results to construction, automotive, electronics, and consumer goods, where demand can shift by 1 to 2 quarters across cycles. That matters because 2025 market mix, margin, and service needs differ by segment, so managers can spot weak demand early and protect pricing discipline. It also keeps sales targets tied to end-market realities, not just total revenue.

Explore a Preview
Icon

Sustainability Tracking

Arkema's sustainability tracking fits a Balanced Scorecard because climate change, resource scarcity, and urbanization hit both cost and demand. In 2025, the scorecard should tie CO2 intensity, energy use, recycled input, and waste reduction to financial KPIs like revenue and EBITDA.

That makes environmental performance visible in the same view as margins, so managers can spot trade-offs fast. It also helps Arkema prove where lower emissions and circular inputs support growth.

Icon

Innovation Discipline

Innovation Discipline ties Arkema's R&D spend to sales, not just lab output. In specialty chemicals, this means tracking launch timing, qualified customer wins, and revenue from new products so managers can see which projects reach market. That matters because Arkema reports 2025 results with innovation-led products at the center of mix, margin, and growth choices.

Icon

Customer Focus

Customer focus helps Arkema track technical support, product quality, and on-time delivery, which are the three service checks that most affect account retention. In high-performance materials, customers face strict qualification rules and high switching costs, so even a small slip can delay reorders or approvals. This view gives Arkema an early signal on service gaps before they turn into lost volume or margin pressure.

Icon

Arkema's 2025 Scorecard Ties Profit, Cash, and Carbon to Performance

Arkema's scorecard benefits are clearer when it links 2025 target setting to cash, margins, and carbon. With 2024 net sales of €9.5bn and a wide mix across Adhesive Solutions, Advanced Materials, and Coating Solutions, managers can spot where growth, cost, and service are working.

Benefit 2025 KPI
Margin control EBITDA
Sustainability CO2 intensity

What is included in the product

Word Icon Detailed Word Document
Analyzes Arkema's strategic performance across financial, customer, internal process, and learning and growth priorities
Plus Icon
Excel Icon Editable Excel File
Provides a quick Arkema Balanced Scorecard snapshot to simplify strategic performance review across financial, customer, internal, and growth priorities.

Drawbacks

Icon

Metric Overload

Arkema's 3 business segments and global footprint across 55 countries can turn a Balanced Scorecard into a KPI maze if each plant, market, and product line gets its own metrics. In 2025, that risk matters more because a 21,000-plus employee group cannot manage dozens of conflicting scorecard signals without losing focus. When managers chase the dashboard, not the few actions that lift margin, cash, and safety, execution gets slower and weaker.

Icon

Data Gaps

Data gaps are a real drawback for Arkema's scorecard because global plants and commercial teams often use different ERP systems, KPI definitions, and reporting cadences. That makes cross-site comparison slower and can blur 2025 performance signals on cost, output, and service quality. When site-level data are not aligned, leaders may trust local reports more than the group view, which weakens decision quality. In practice, the issue is not missing data alone; it is inconsistent data.

Explore a Preview
Icon

Slow Signals

Slow signals are a real drawback for Arkema because product launches, customer qualification, and plant ramp-ups can take several quarters to show up in results. A quarterly scorecard can miss early shifts in pricing, adoption, or utilization, so managers may react late. In a cyclical market like specialty materials, that lag can hide weakness until it already hits margin and cash flow.

Icon

Implementation Burden

Implementation burden is a real downside of Arkema Balanced Scorecard Analysis because a useful scorecard needs regular review, clear owners, and steady targets. That adds recurring work for finance, operations, sales, and sustainability teams, not just one-off setup.

In Arkema's 2025 reporting cycle, that means more time spent aligning KPIs, checking data quality, and reconciling cross-team targets. If ownership is vague, the scorecard can turn into admin overhead instead of a decision tool.

Icon

Attribution Risk

Attribution risk is high at Arkema because profit can improve for several reasons at once. Price, mix, feedstock costs, and demand often move together, so a higher 2025 EBITDA does not prove one KPI caused it.

That makes Balanced Scorecard links weaker: a sales, cost, or quality KPI may look right, but the profit gain may come from lower raw-material costs or a better product mix. In chemicals, cause and effect is usually shared, not clean.

Icon

Arkema's Balanced Scorecard: Too Complex for Fast 2025 Decision-Making

Arkema's Balanced Scorecard can get too complex in 2025 because its 21,000-plus staff, 55-country footprint, and 3 segments create many KPIs, slower reviews, and higher admin load. Different ERP systems and local KPI rules can also weaken data consistency, so managers may trust site reports more than group-level signals. In cyclical chemicals, that lag can hide margin and cash pressure.

Drawback 2025 signal
Complexity 55 countries, 3 segments
Data mismatch Different ERP/KPI rules
Lag Quarterly signals can miss shifts

What You See Is What You Get
Arkema Reference Sources

This is the actual Arkema Balanced Scorecard Analysis document you'll receive after purchase – no surprises, just the full report. The preview below is taken directly from the complete file, so what you see is exactly what you'll get. Unlock the full, detailed version immediately after checkout.

Explore a Preview

Frequently Asked Questions

It measures how Arkema turns strategy into results across finance, customers, operations, and talent. For a company with 3 core segments and exposure to 4 major end markets, useful indicators include operating margin, free cash flow, CO2 intensity, on-time delivery, and R&D cycle time. That mix shows whether growth is profitable and durable.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.